GlassScriptPhysician profile
Angela P Adkins
NPI 1447310768
$2,291.66
in general payments reported to CMS, 2019-2025
20 companies · $407 in 2025
The $407 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $408 · 2020: $225 · 2021: $281 · 2022: $345 · 2023: $332 · 2024: $294 · 2025: $407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $974 · Education: $58.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $973.80 |
| Education | $58.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $435.84 | 2019-2025 | |
| Glaxosmithkline, LLC. | $255.81 | 2020-2025 | Nucala |
| Novartis Pharmaceuticals Corporation | $237.41 | 2019-2024 | |
| Acclarent, INC | $219.81 | 2019-2023 | Acclarent Navwire |
| Genzyme Corporation | $205.96 | 2019-2024 | |
| Regeneron Healthcare Solutions, INC. | $164.89 | 2024-2025 | Dupixent |
| Grifols USA, LLC | $153.47 | 2020-2023 | Xembify |
| Aerin Medical INC. | $112.86 | 2022-2023 | |
| Pacira Pharmaceuticals Incorporated | $102.98 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $91.10 | 2020-2025 | Tezspire |
| Kaleo, INC. | $90.89 | 2022-2024 | Auvi-Q |
| Takeda Pharmaceuticals U.S.A., INC. | $43.63 | 2021 | |
| Blueprint Medicines Corporation | $36.12 | 2023 | |
| Hikma Pharmaceuticals USA | $34.65 | 2024-2025 | Ryaltris |
| Stryker Corporation | $34.08 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $19.97 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $17.22 | 2025 | Neffy |
| Inspire Medical Systems, INC. | $15.37 | 2025 | Inspire |
| Glenmark Therapeutics INC. | $10.00 | 2019 | |
| Checkpoint Surgical, INC | $9.60 | 2025 | Checkpoint Stimulators |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Adkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.